ARTICLE | Company News
Roche extends Vernalis agreement
March 20, 2001 8:00 AM UTC
F. Hoffmann-La Roche (SWX:ROCZ) and Vernalis (LSE:VER) extended their 1999 obesity agreement, agreeing to take a 5-HT2C receptor agonist into preclinical development. VER received a milestone payment ...